179 related articles for article (PubMed ID: 8783779)
41. Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients.
Persson B; Stimpel M
Eur J Clin Pharmacol; 1996; 50(4):259-64. PubMed ID: 8803515
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the efficacy and safety of quinapril vs. captopril in treatment of moderate to severe hypertension.
Schnaper HW
Angiology; 1989 Apr; 40(4 Pt 2):389-95. PubMed ID: 2650582
[TBL] [Abstract][Full Text] [Related]
43. The treatment of mild to moderate hypertension with ACE inhibitors.
Taylor SH
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S24-8. PubMed ID: 1691403
[TBL] [Abstract][Full Text] [Related]
44. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
45. The treatment of moderate to severe hypertension with ACE inhibitors.
Goldstein RJ
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S29-35. PubMed ID: 1691404
[TBL] [Abstract][Full Text] [Related]
46. Speed and duration of dose titration with the angiotensin converting enzyme inhibitor quinapril: relationship with efficacy in patients with moderate hypertension.
Weir MR
J Hum Hypertens; 1994 Sep; 8(9):725-30. PubMed ID: 7807504
[TBL] [Abstract][Full Text] [Related]
47. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
Culy CR; Jarvis B
Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
[TBL] [Abstract][Full Text] [Related]
48. The response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording.
MacFadyen RJ; Bainbridge AD; Lees KR; Reid JL
Br J Clin Pharmacol; 1991 Sep; 32(3):393-8. PubMed ID: 1777377
[TBL] [Abstract][Full Text] [Related]
49. Angiotensin-converting enzyme inhibition by quinapril blocks the albuminuric effect of atrial natriuretic peptide in Type 1 diabetes and microalbuminuria.
McKenna K; Smith D; Barrett P; Glenn A; Kesson CM; Connell J; Thompson CJ
Diabet Med; 2000 Mar; 17(3):219-24. PubMed ID: 10784227
[TBL] [Abstract][Full Text] [Related]
50. Effect of an alpha-adrenergic blocker, and ACE inhibitor and hydrochlorothiazide on blood pressure and on renal function in type 2 diabetic patients with hypertension and albuminuria. A randomized cross-over study.
Rachmani R; Levi Z; Slavachevsky I; Half-Onn E; Ravid M
Nephron; 1998 Oct; 80(2):175-82. PubMed ID: 9736816
[TBL] [Abstract][Full Text] [Related]
51. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Plosker GL; Sorkin EM
Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
[TBL] [Abstract][Full Text] [Related]
52. Quinapril versus enalapril in the treatment of mild-to-moderate essential hypertension.
Sánchez S; Luna A; Orozco R; Velasco G
Clin Ther; 1991; 13(5):651-5. PubMed ID: 1799922
[TBL] [Abstract][Full Text] [Related]
53. The safety and efficacy of quinapril in the treatment of mild to moderate essential hypertension.
Frishman WH
Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII19-25. PubMed ID: 2189617
[TBL] [Abstract][Full Text] [Related]
54. Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group.
Os I; Hotnes T; Dollerup J; Mogensen CE
Am J Hypertens; 1997 Aug; 10(8):899-904. PubMed ID: 9270085
[TBL] [Abstract][Full Text] [Related]
55. [Life-threatening postoperative angioedema following treatment with an angiotensin converting enzyme inhibitor].
Maier C
Anaesthesist; 1995 Dec; 44(12):875-9. PubMed ID: 8594963
[TBL] [Abstract][Full Text] [Related]
56. Effect of quinapril therapy on blood pressure and serotonin change in patients with mild to moderate hypertension.
Huang JL; Cheng FC; Chen YT; Ting CT
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):329-34. PubMed ID: 9037848
[TBL] [Abstract][Full Text] [Related]
57. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
[TBL] [Abstract][Full Text] [Related]
58. Quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
Lenz T; Schulte KL; Wagner B; Lilienthal J; Gotzen R
Eur Heart J; 1994 Jul; 15(7):940-6. PubMed ID: 7925516
[TBL] [Abstract][Full Text] [Related]
59. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
Ostman J; Asplund K; Bystedt T; Dahlöf B; Jern S; Kjellström T; Lithell H
J Intern Med; 1998 Aug; 244(2):95-107. PubMed ID: 10095796
[TBL] [Abstract][Full Text] [Related]
60. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
